Tan et al.13 found that targeting EGFR-AS1 with a Locked Nucleic Acid (LNA) in vivo was sufficient to induce sustained squamous cell carcinoma regression in comparison to controls. This evidence concerns the gene EGFR and squamous cell carcinoma.